Suzanne Wright and The Wensley Hefni 2011 Irrevocable Trust v. Silver Creek Pharmaceuticals, Inc.
Opinion
COURT OF CHANCERY
OF THE
STATE OF DELAWARE
LORI W. WILL LEONARD L. WILLIAMS JUSTICE CENTER VICE CHANCELLOR 500 N. KING STREET, SUITE 11400 WILMINGTON, DELAWARE 19801-3734 Date Submitted: February 27, 2024 Date Decided: March 27, 2024
Kevin M. Gallagher, Esquire Lisa M. Zwally, Esquire Andrew L. Milam, Esquire Greenberg Traurig, LLP Richards, Layton & Finger, P.A. 222 Delaware Avenue 920 North King Street Suite 1600 Wilmington, Delaware 19801 Wilmington, Delaware 19801
RE: Wright et al. v. Silver Creek Pharmaceuticals, Inc., C.A. No. 2023-1044-LWW
Dear Counsel:
This action is brought by stockholders of Silver Creek Pharmaceuticals, Inc., who seek to compel an annual meeting under 8 Del. C. § 211. Silver Creek insists that I should reject the plaintiffs’ request because it acted by written consent in lieu of a meeting. For the reasons discussed in this letter opinion, the written consent is insufficient. The matter is resolved in favor of the plaintiffs insofar as Silver Creek must promptly hold an annual meeting. I. BACKGROUND The following background is drawn from the undisputed facts in the pleadings and evidence presented by the parties.
Defendant Silver Creek Pharmaceuticals, Inc. (the “Company”) is a Delaware corporation with its principal place of business in San Francisco,
March 27, 2024 Page 2 of 9
California.1 Plaintiffs Suzanne Wright and The Wesley Hefni 2011 Irrevocable Trust are Silver Creek stockholders.2 According to Article II, Section 2.2 of Silver Creek’s bylaws:
Annual meetings of stockholders, commencing within the year 2010, shall be held at such date and time as shall be designated from time to time by the Board of Directors and stated in the notice of the meeting, at which they shall elect by a plurality vote a Board of Directors, and transact such other business as may properly be brought before the meeting.3
Section 2.3 of Article III requires that “written notice of any stockholder meeting . . . be given to each stockholder entitled to vote at such meeting not fewer than ten (10) nor more than sixty (60) days before the date of the meeting.”4 Silver Creek has not held an annual meeting “in the last 13 months, if not significantly longer.”5 On October 17, 2023, the plaintiffs filed a complaint asking the court to direct Silver Creek to hold an annual meeting for the election of its
1 Verified Compl. Pursuant to 8 Del. C. § 211 (Dkt. 1) (“Compl.”) ¶ 4; Answer to Verified Am. Comp. (Dkt. 10) (“Answer”) ¶ 4. 2 Compl. ¶¶ 2, 3; Answer ¶¶ 2, 3.
3 Compl. ¶ 6; Answer ¶ 6.
4 Compl. ¶ 6; Answer ¶ 6.
5 Compl. ¶ 7; Answer ¶ 7.
March 27, 2024 Page 3 of 9
directors and any other board vacancies pursuant to 8 Del. C. § 211(c).6 On November 6, Silver Creek answered the complaint.7 On December 8, the plaintiffs filed a motion for judgment on the pleadings.8 Silver Creek filed a response contending that this action was mooted by a purported stockholder written consent.9 According to Silver Creek, it obtained consents from over 70% of its stockholders to elect directors in lieu of holding an annual meeting.10 In their reply, the plaintiffs argued that the purported written consent did not moot their motion.11 As I explained at oral argument on January 3, 2024, the parties’ submissions caused a procedural quandary.12 Silver Creek’s opposition to the plaintiffs’ motion relied on an unsigned version of a stockholder written consent that was outside the pleadings. Yet if Silver Creek had—as it insisted—properly acted by written consent pursuant to Section 211(b), it would be needless to order it to hold an annual meeting. I therefore asked that Silver Creek produce materials supporting
6 See Compl. ¶ 13.
7 Dkt. 10.
8 Pls.’ Mot. for J. on the Pleadings (Dkt. 12).
9 Def.’s Response to Pls.’ Mot. for J. on the Pleadings (Dkt. 16) (“Def.’s Response”).
10 Id. ¶ 12.
11 Pls.’ Reply in Further Supp. of their Mot. for J. on the Pleadings (Dkt. 20) (“Pls.’ Reply”) ¶ 9. 12 See Trans. of Jan. 3, 2024 Oral Arg. on Pls.’ Mot. for J. on the Pleadings (Dkt. 34).
March 27, 2024 Page 4 of 9
its assertion that the action taken by written consent in lieu of an annual meeting satisfied the statute.
On January 10, Silver Creek’s counsel provided the court with copies of executed consents and a chart listing the stockholders who had signed them.13 After the plaintiffs’ counsel argued that they were also entitled to review the materials,14 I ordered Silver Creek to file copies of the consents on the docket.15 The documents were filed on January 30.16 On February 6, the plaintiffs filed a letter arguing that the information provided by Silver Creek was insufficient to moot this action. 17 They raised a series of perceived deficiencies, including that the consent was non-compliant with Section 211(b). On February 27, Silver Creek filed a letter stating that it believes the court is in receipt of all requested papers regarding the Company’s action by written consent.18 I deemed the matter under advisement at that time.
13 Dkt. 28; see also Dkt. 27.
14 See Dkts. 29, 30.
15 Dkt. 32. I permitted Silver Creek to redact certain identifying information. Id.
16 Dkt. 33.
17 Dkt. 35.
18 Dkt. 36.
March 27, 2024 Page 5 of 9
II. ANALYSIS “This court will grant a motion for judgment on the pleadings pursuant to Court of Chancery Rule 12(c) when there are no material issues of fact and the movant is entitled to judgment as a matter of law.”19 Because both parties have relied on evidence outside the pleadings and had ample opportunity to present pertinent material, the plaintiffs’ motion will be treated as one for summary judgment under Rule 56.20 The standard guiding my analysis is the same.21 Section 211(c) of the Delaware General Corporation Law provides that this court may summarily order a company to hold an annual meeting if it has failed to timely “hold the annual meeting or take action by written consent to elect directors in lieu of an annual meeting.”22 “[A] prima facie case is made out pursuant to 8 Del. C. § 211 when (1) the petitioner is a stockholder, and (2) no meeting has been held for over thirteen months.”23 There is no dispute that the plaintiffs are stockholders and that Silver Creek has not held an annual meeting for at least that
19 McMillan v. Intercargo Corp., 768 A.2d 492, 499 (Del. Ch. 2000).
20 Ct. Ch. R. 12(c) (“If, on a motion for judgment on the pleadings, matters outside the pleadings are presented to and not excluded by the Court, the motion shall be treated as one for summary judgment and disposed of as provided in Rule 56[.]”). 21 See Ct. Ch. R. 56(c).
22 8 Del. C. § 211(c).
Opportunity P’rs, L.P. v. Transtech Serv. P’rs Inc., 2009 WL 997334, at *3 (Del. Ch. 23
Apr. 14, 2009).
March 27, 2024 Page 6 of 9
time period. Instead, Silver Creek asserts that this action is moot because directors were elected by written consent in lieu of a meeting pursuant to Section 211(b).24 Section 211(b) requires that “all of the directorships to which directors could be elected at an annual meeting held at the effective time of such action are vacant and are filled by such” non-unanimous written consent.25 “To operate in lieu of an annual meeting, a non-unanimous written consent . . . must first remove all sitting directors and then fill the resulting vacancies. Stockholders cannot use a non- unanimous written consent to remove lawfully serving incumbent directors, and then elect successor directors, between annual meetings.”26 Silver Creek’s purported written consent contravenes these requirements.
The Company “obtained consents from over 70% of its shareholders, but less than unanimous consent” such that “the prior Board was vacated and all directorships were filled by written consent.”27 The unsigned version of the stockholder consent filed with Silver Creek’s response to the motion states that “all directors of the
24 Def.’s Response ¶¶ 1, 11.
Free access — add to your briefcase to read the full text and ask questions with AI
Suzanne Wright and The Wensley Hefni 2011 Irrevocable Trust v. Silver Creek Pharmaceuticals, Inc. (Suzanne Wright and The Wensley Hefni 2011 Irrevocable Trust v. Silver Creek Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.